Don’t Miss These Interactive Headliner Sessions
Get the pulse on biotech policy and investment trends, learn about therapeutic breakthroughs and hear from visionaries working to tackle today’s challenges. Note all times are in Eastern Standard Time (EST).
- BIO President & CEO, Dr. Michelle McMurry-Heath will welcome attendees and speak with Nasdaq’s CEO, Adena T. Friedman during Biotech's Finest Hour on Tuesday at 10:15 AM EST.
- Fireside Chat: Rahul Singhvi, Sc.D., MBA, Chief Executive Officer and Director, National Resilience, Inc., with Michael E. Meyers, MPH, Vice Chairman, Head of M&A and Strategic Advisory Services, H.C. Wainwright & Co., LLC on Tuesday at 12:00 pm EST.
- “SPACs: Criteria for Successful Launches” with Chardan’s President Jonas Grossman on Tuesday at 2:00 pm EST.
- Hear critical insights on China as an Emerging Center of Innovation, Tuesday at 3:00 pm EST.
- Preview new research during Clinical Success Rates and What is Driving Them on Wednesday at 9:00 AM EST.
- A conversation with Mary Haak-Frendscho, PhD, CEO of Spotlight Therapeutics on “CRISPR’s Progress for Patients: Clinical Development of Therapies” on Wednesday at 10:00 am EST.
- RA Capital’s Peter Kolchinsky sharing a new presentation on reference pricing’s impact on investment, matched with a policy forecast on Wednesday at 11:00 AM EST.
- Fireside Chat: Adam M. Koppel, MD, PhD, Managing Director, Life Sciences, Bain Capital, LP, with Neal J. Reenan, Partner, Latham & Watkins LLP on Wednesday at 12:00 pm EST.
- Learn industry and policy experts' take on Advancing Biopharma Goals in Congress and the White House on Wednesday at 2:00 PM EST.
- CLOSING PLENARY: “Market Outlook’ panel with Bayer’s Marianne De Backer, JPMorgan’s Phil Ross, and more, on Wednesday at 4:00 pm EST.
130+ On-Demand Company Presentations: Start searching the library of Company Presentations over the weekend, and request meetings with them in BIO One-on-One Partnering next week!
Extended Access to Content: You will have access to the education platform and sessions until March 16, 2021